HQ Function

Formerly served as the main center for research and development, clinical trial oversight, and corporate administration for Regeneus's portfolio of regenerative therapies.

Notable Features:

Likely equipped with specialized laboratory facilities essential for stem cell research, culture, processing, and cryopreservation, adhering to Good Manufacturing Practice (GMP) standards for clinical-grade products.

Work Culture:

As a clinical-stage biotechnology firm, the work culture probably fostered innovation, scientific excellence, intensive research, and a collaborative spirit aimed at addressing significant unmet medical needs.

HQ Significance:

The headquarters was historically crucial as the operational base where Regeneus developed its proprietary Sygenus and Progenza stem cell technologies and managed its clinical programs.

Values Reflected in HQ: The headquarters likely embodied values of scientific innovation, dedication to quality in research and manufacturing, and a commitment to developing therapeutic solutions for patients.

Location:

Historically, Regeneus Ltd's global activities were primarily focused on its clinical trials, which occasionally involved international sites, and through strategic partnerships for research or commercialization, notably with Kyocera Corporation in Japan for its knee osteoarthritis product. The company aimed for global market access for its therapies. Post-acquisition, its global strategy is integrated with Algorae Pharmaceuticals.

Street Address:

Suite 201, Level 2, 20 Bridge Street (Historical)

City:

Pymble

State/Province:

NSW

Country:

Australia